129 related articles for article (PubMed ID: 29903892)
21. Macrothrombocytopenia With Congenital Bilateral Cataracts: A Phenotype of MYH9 Disorder With Exon 24 Indel Mutations.
Aoki T; Kunishima S; Yamashita Y; Minamitani K; Ota S
J Pediatr Hematol Oncol; 2018 Jan; 40(1):76-78. PubMed ID: 29200148
[TBL] [Abstract][Full Text] [Related]
22. [A non-familial May-Hegglin anomaly accompanying with MYH9 gene R1933X mutation and I1626V polymorphism].
Li Y; Wang YW; Zhang GS; Fang MY
Zhonghua Xue Ye Xue Za Zhi; 2009 Sep; 30(9):577-81. PubMed ID: 19954613
[TBL] [Abstract][Full Text] [Related]
23. Familial cases with MYH9 disorders caused by MYH9 S96L mutation.
Murayama S; Akiyama M; Namba H; Wada Y; Ida H; Kunishima S
Pediatr Int; 2013 Feb; 55(1):102-4. PubMed ID: 23409987
[TBL] [Abstract][Full Text] [Related]
24. Nonmuscle myosin IIA is required for lamellipodia formation through binding to WAVE2 and phosphatidylinositol 3,4,5-triphosphate.
Morimura S; Suzuki K; Takahashi K
Biochem Biophys Res Commun; 2011 Jan; 404(3):834-40. PubMed ID: 21184743
[TBL] [Abstract][Full Text] [Related]
25. MYH9-macrothrombocytopenia caused by a novel variant (E1421K) initially presenting as apparent neonatal alloimmune thrombocytopenia.
Samelson-Jones BJ; Kramer PM; Chicka M; Gunning WT; Lambert MP
Pediatr Blood Cancer; 2018 Apr; 65(4):. PubMed ID: 29286575
[TBL] [Abstract][Full Text] [Related]
26. MYH9-related platelet disorders.
Althaus K; Greinacher A
Semin Thromb Hemost; 2009 Mar; 35(2):189-203. PubMed ID: 19408192
[TBL] [Abstract][Full Text] [Related]
27. Functional Effects of SNPs in MYH9 and Risks of Nonsyndromic Orofacial Clefts.
Wang Y; Li D; Xu Y; Ma L; Lu Y; Wang Z; Wang L; Zhang W; Pan Y
J Dent Res; 2018 Apr; 97(4):388-394. PubMed ID: 29207917
[TBL] [Abstract][Full Text] [Related]
28. [Clinical features and genetic analysis of a pedigree affected with non-muscle myosin heavy chain 9 gene related disease].
Zeng Q; Han Y; Huang L; Ji H; Du Y; Yang N; Xu Q; Huang S
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Apr; 36(4):352-356. PubMed ID: 30950024
[TBL] [Abstract][Full Text] [Related]
29. Haematological characteristics of MYH9 disorders due to MYH9 R702 mutations.
Kunishima S; Yoshinari M; Nishio H; Ida K; Miura T; Matsushita T; Hamaguchi M; Saito H
Eur J Haematol; 2007 Mar; 78(3):220-6. PubMed ID: 17241369
[TBL] [Abstract][Full Text] [Related]
30. Myosin Heavy Chain 9: Oncogene or Tumor Suppressor Gene?
Wang Y; Liu S; Zhang Y; Yang J
Med Sci Monit; 2019 Jan; 25():888-892. PubMed ID: 30739906
[TBL] [Abstract][Full Text] [Related]
31. Perioperative management of MYH9 hereditary macrothrombocytopenia (Fechtner syndrome).
Selleng K; Lubenow LE; Greinacher A; Warkentin TE
Eur J Haematol; 2007 Sep; 79(3):263-8. PubMed ID: 17655694
[TBL] [Abstract][Full Text] [Related]
32. Patients with Epstein-Fechtner syndromes owing to MYH9 R702 mutations develop progressive proteinuric renal disease.
Sekine T; Konno M; Sasaki S; Moritani S; Miura T; Wong WS; Nishio H; Nishiguchi T; Ohuchi MY; Tsuchiya S; Matsuyama T; Kanegane H; Ida K; Miura K; Harita Y; Hattori M; Horita S; Igarashi T; Saito H; Kunishima S
Kidney Int; 2010 Jul; 78(2):207-14. PubMed ID: 20200500
[TBL] [Abstract][Full Text] [Related]
33. Germinal mosaicism in MYH9 disorders: a family with two affected siblings of normal parents.
Kunishima S; Takaki K; Ito Y; Saito H
Br J Haematol; 2009 Apr; 145(2):260-2. PubMed ID: 19208103
[No Abstract] [Full Text] [Related]
34. Mutations in MYH9 exons 1, 16, 26, and 30 are infrequently found in Japanese patients with nonsyndromic deafness.
Kunishima S; Matsunaga T; Ito Y; Saito H
Genet Test Mol Biomarkers; 2009 Oct; 13(5):705-7. PubMed ID: 19645626
[TBL] [Abstract][Full Text] [Related]
35. First description of somatic mosaicism in MYH9 disorders.
Kunishima S; Matsushita T; Yoshihara T; Nakase Y; Yokoi K; Hamaguchi M; Saito H
Br J Haematol; 2005 Feb; 128(3):360-5. PubMed ID: 15667538
[TBL] [Abstract][Full Text] [Related]
36. High-resolution melting analysis for detection of MYH9 mutations.
Provaznikova D; Kumstyrova T; Kotlin R; Salaj P; Matoska V; Hrachovinova I; Rittich S
Platelets; 2008 Sep; 19(6):471-5. PubMed ID: 18925516
[TBL] [Abstract][Full Text] [Related]
37. A rare case of MYH9 disorders presenting with macrothrombocytopenia and deafness caused by MYH9-R702C mutation.
Kodama R; Taketani T; Kunishima S; Mishima S; Yoshikawa Y; Kanai R; Suyama T; Yoshino I; Kunishi H; Shibata H; Nagai A; Yamaguchi S; Masuda J
Thromb Res; 2009 Sep; 124(4):508-11. PubMed ID: 19250658
[No Abstract] [Full Text] [Related]
38. The irreversibility of platelet aggregation is regulated by myosin IIA, but is not compromised in MYH9-related disease.
Catricalà S; Guidetti GF; Canobbio I; Pecci A; Balduini CL; Balduini C; Torti M
Thromb Res; 2011 Feb; 127(2):171-3. PubMed ID: 20828798
[No Abstract] [Full Text] [Related]
39. Association of a novel in-frame deletion mutation of the MYH9 gene with end-stage renal failure: case report and review of the literature.
Ishida M; Mori Y; Ota N; Inaba T; Kunishima S
Clin Nephrol; 2013 Sep; 80(3):218-22. PubMed ID: 22541678
[TBL] [Abstract][Full Text] [Related]
40. Identification of the first in cis mutations in MYH9 disorder.
Miyajima Y; Kunishima S
Eur J Haematol; 2009 Apr; 82(4):288-91. PubMed ID: 19191864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
